| From Ukraine to the Middle East, GPS Disruption Drives Demand for Next-Generation Defense Technology |
Globe Newswire |
04/20 |
08:30 |
| INVESTOR DEADLINE: Eos Energy (EOSE) Investors with Substantial Losses Have Opportunity to Lead the Eos Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:27 |
| INVESTOR DEADLINE: Driven Brands (DRVN) Investors with Substantial Losses Have Opportunity to Lead the Driven Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:26 |
| Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America |
Globe Newswire |
04/20 |
08:20 |
| INVESTOR DEADLINE: Apollo Global Management (APO) Investors with Substantial Losses Have Opportunity to Lead the Apollo Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:18 |
| Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions |
Globe Newswire |
04/20 |
08:15 |
| Bitcoin Casino No Deposit Bonus 2026: BitStarz Launches 50 Free Spins No Deposit Bonus with Instant Withdrawals |
Globe Newswire |
04/20 |
08:08 |
| YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026 |
Globe Newswire |
04/20 |
08:07 |
| dLocal Limited Announces Dismissal of New York State Securities Class Action |
Globe Newswire |
04/20 |
08:05 |
| Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return |
Globe Newswire |
04/20 |
08:02 |
| Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day |
Globe Newswire |
04/20 |
08:01 |
| Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks |
Globe Newswire |
04/20 |
08:00 |
| Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 |
Globe Newswire |
04/20 |
08:00 |
| Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 |
Globe Newswire |
04/20 |
08:00 |
| Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income |
Globe Newswire |
04/20 |
08:00 |
| Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest |
Globe Newswire |
04/20 |
08:00 |
| COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations |
Globe Newswire |
04/20 |
08:00 |
| ASML reports transactions under its current share buyback program |
Globe Newswire |
04/20 |
08:00 |
| Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 |
Globe Newswire |
04/20 |
08:00 |
| Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure |
Globe Newswire |
04/20 |
08:00 |
| Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer |
Globe Newswire |
04/20 |
08:00 |
| Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 |
Globe Newswire |
04/20 |
08:00 |
| MainStreet Bancshares, Inc. Announces First Quarter 2026 Results |
Globe Newswire |
04/20 |
08:00 |
| LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas |
Globe Newswire |
04/20 |
08:00 |
| AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease |
Globe Newswire |
04/20 |
08:00 |
